小儿柴桂退热口服液联合奥司他韦治疗小儿甲型流感临床研究
Clinical study on the combination of Xiaoer Chaigui Antipyretic Oral Liquid and Oseltamivir in the treatment of pediatric influenza A
ES评分 0
| DOI |
10.12208/j.ijcr.20250083 |
| 刊名 |
International Journal of Clinical Research
|
| 年，卷(期) |
2025, 9(2) |
| 作者 |
|
| 作者单位 |
定西市第二人民医院 甘肃定西
|
| 摘要 |
目的 探究小儿甲型流感治疗中，小儿柴桂退热口服液与奥司他韦联合应用的临床效应研究。方法在本文将200例小儿甲型流感患儿作为研究对象，收治时间在2023年3月-2023年5月之间，随机分组为两组（每组100例患儿）。结果 观察组患儿治疗总有效率经过治疗后，观察组患儿Hs-CRP低于对照组（P＜0.05）；观察组发热持续时间、咽喉肿痛持续时间（均短于对照组的持续时间（P＜0.05）；观察组患儿不良反应发生率2.00%低于对照组（P＜0.05）。结论 小儿甲型流感治疗中，联合应用小儿柴桂退热口服液与奥司他韦，其临床成效尤为突出，能够促进病情早期恢复。
|
| Abstract |
Objective To investigate the clinical study of the combination of Xiaoer Chaigui Antipyretic Oral Liquid and Oseltamivir in the treatment of pediatric influenza A. Methods In this study, 200 pediatric patients with influenza A were selected as the research subjects. They were admitted between March 2023 and May 2023 and randomly divided into two groups (100 patients in each group). Results After treatment, the total effective rate of Hs CRP in the observation group was lower than that in the control group (P<0.05); The duration of fever and sore throat in the observation group were shorter than those in the control group (P<0.05); The incidence of adverse reactions in the observation group was 2.00% lower than that in the control group (P<0.05). Conclusion The combination of Xiaoer Chaigui Antipyretic Oral Liquid and Oseltamivir is highly effective in treating pediatric influenza A, promoting early recovery of the condition.
|
| 关键词 |
小儿柴桂退热口服液；奥司他韦；小儿甲型流感
|
| KeyWord |
Xiaoer Chaigui Antipyretic Oral Liquid; Oseltamivir; Pediatric influenza A
|
| 基金项目 |
|
| 页码 |
93-96 |
杜徽*,何海燕.
小儿柴桂退热口服液联合奥司他韦治疗小儿甲型流感临床研究 [J].
国际临床研究杂志.
2025; 9; (2).
93 - 96.